Novel PMM2 missense mutation in a Chinese family with non-syndromic premature ovarian insufficiency

J Assist Reprod Genet. 2020 Feb;37(2):443-450. doi: 10.1007/s10815-019-01675-8. Epub 2020 Jan 4.

Abstract

Purpose: This study sought to identify a disease-related gene in a consanguineous Chinese family in which there were two premature ovarian insufficiency (POI) sisters.

Method: We used whole-exome sequencing and Sanger sequencing to identify the disease-causing gene. Results were verified using an assay of mutant protein and in silico analyses.

Result: We identified a novel missense mutation (NM_000303: c.556G>A, p.Gly186Arg) in the PMM2 gene. The two sisters suffer from premature ovarian insufficiency (POI) only and have no other symptoms of congenital disorder of glycosylation type-1a (CDG-Ia). We found that the enzymic activity of the mutant PMM2 protein was reduced by 55.21% (p < 0.05) when compared with wild type, and many in silico tools suggested the mutation is disease-related.

Conclusion: This particular gene modification results in changes in activity of phosphomannomutase modification, which could lead to PMM2-CDG-Ia with an uncommon phenotype.

Keywords: Congenital disorder of glycosylation type-1a (CDG-Ia); Non-syndromic premature ovarian insufficiency; PMM2; Premature ovarian insufficiency (POI).

MeSH terms

  • Adult
  • China
  • Consanguinity
  • Female
  • Genetic Predisposition to Disease*
  • Humans
  • Mutation, Missense / genetics
  • Pedigree
  • Phenotype
  • Phosphotransferases (Phosphomutases) / genetics*
  • Primary Ovarian Insufficiency / genetics*
  • Primary Ovarian Insufficiency / physiopathology
  • Siblings

Substances

  • Phosphotransferases (Phosphomutases)
  • phosphomannomutase 2, human